Insight Molecular Diagnostics - 10 Year Stock Price History | IMDX
- The all-time high Insight Molecular Diagnostics stock closing price was 202.20 on January 05, 2016.
- The Insight Molecular Diagnostics 52-week high stock price is 4.75, which is 93.9% above the current share price.
- The Insight Molecular Diagnostics 52-week low stock price is 1.92, which is 21.6% below the current share price.
- The average Insight Molecular Diagnostics stock price for the last 52 weeks is 2.85.
Insight Molecular Diagnostics Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 2.8502 | 2.3300 | 4.2400 | 1.9600 | 2.4500 | 2.94% |
2024 | 2.9132 | 3.3000 | 3.6000 | 2.1100 | 2.3800 | -4.80% |
2023 | 4.8035 | 6.9000 | 9.7600 | 2.0800 | 2.5000 | -61.06% |
2022 | 20.6963 | 45.0000 | 45.0000 | 5.0800 | 6.4200 | -85.21% |
2021 | 85.3492 | 47.8000 | 130.0000 | 40.8000 | 43.4000 | -9.21% |
2020 | 41.4055 | 44.6000 | 69.0000 | 24.0000 | 47.8000 | 6.22% |
2019 | 55.5357 | 29.4000 | 118.2000 | 29.4000 | 45.0000 | 63.04% |
2018 | 50.6016 | 92.0000 | 92.0000 | 25.0000 | 27.6000 | -70.32% |
2017 | 111.6787 | 135.0000 | 151.0000 | 72.0000 | 93.0000 | -34.04% |
2016 | 93.2116 | 180.0000 | 202.2000 | 52.4000 | 141.0000 | 12.80% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.070B | $0.002B |
Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.621B | 58.04 |
Tempus AI (TEM) | United States | $12.054B | 0.00 |
Doximity (DOCS) | United States | $12.025B | 53.35 |
Hims & Hers Health (HIMS) | United States | $10.818B | 89.50 |
IRhythm Technologies (IRTC) | United States | $5.361B | 0.00 |
Hinge Health (HNGE) | United States | $4.529B | 0.00 |
Inspire Medical Systems (INSP) | United States | $2.584B | 37.98 |
Privia Health (PRVA) | United States | $2.580B | 191.09 |
Phreesia (PHR) | United States | $1.705B | 0.00 |
Enovis (ENOV) | United States | $1.691B | 8.94 |
10x Genomics (TXG) | United States | $1.671B | 0.00 |
Azenta (AZTA) | United States | $1.471B | 64.16 |
Schrodinger (SDGR) | United States | $1.456B | 0.00 |
Omnicell (OMCL) | United States | $1.440B | 27.74 |
Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
Claritev (CTEV) | United States | $1.157B | 0.00 |
Evolent Health (EVH) | United States | $1.053B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
Veradigm (MDRX) | United States | $0.509B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.504B | 0.00 |
Standard BioTools (LAB) | United States | $0.498B | 0.00 |
Talkspace (TALK) | United States | $0.432B | 129.00 |
Carlsmed (CARL) | $0.365B | 0.00 | |
Butterfly Network (BFLY) | United States | $0.357B | 0.00 |
TruBridge (TBRG) | United States | $0.300B | 52.66 |
Outset Medical (OM) | United States | $0.235B | 0.00 |
Health Catalyst (HCAT) | United States | $0.227B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.210B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.199B | 0.00 |
CapsoVision (CV) | United States | $0.189B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.130B | 0.00 |
American Well (AMWL) | United States | $0.112B | 0.00 |
CareCloud (CCLD) | United States | $0.108B | 4.90 |
EUDA Health Holdings (EUDA) | Singapore | $0.095B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
Pulmonx (LUNG) | United States | $0.063B | 0.00 |
111 (YI) | China | $0.054B | 0.00 |
P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
HeartBeam (BEAT) | United States | $0.041B | 0.00 |
Zhongchao (ZCMD) | China | $0.025B | 0.00 |
Precipio (PRPO) | United States | $0.022B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.008B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.007B | 0.00 |
MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
PROFUSA (PFSA) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |